MRC Clinical Trials Unit at UCL
Menu
Home
About
Our Structure
Our People
'25 at 25' series
Our Environmental Commitment
News
Research
Cancer
Add-Aspirin
ARCHERY
RAMPART
REFINE
STAMPEDE
STAMPEDE2
STOPCAP
UKCTOCS
PATCH
Open studies
Past Studies
Infections
Studies by Research Area
Neurodegenerative Diseases
ACORD collaboration
MRC Clinical Trials Unit ACORD Fellows Academy
OCTOPUS
EJS ACT-PD
Methodology
Design
Conduct
Analysis
Meta-analysis
Software
Other Research & Policy
Data Sharing
Publications
Studies in other areas
Briefing Papers
Regulatory information, Toolkits & Templates
Our podcast
Studies
All Studies
Studies Search
Patients & Public
About Clinical Trials
What is a clinical trial?
What is a randomised clinical trial?
What is an observational study?
How do we make sure a trial is safe?
How is a trial designed and run?
What happens at the end of a trial?
Taking Part in a Clinical Trial
How can you take part in a trial?
What questions should you ask before participating in a trial?
Patient and Public Involvement
About our PPI group
Our PPI Strategy
PPI Resources
Study & Careers
Capacity Strengthening
Enhancing skills of trial teams we work with across the globe
Improving the clinical trials ecosystem
NIHR Associate Principal Investigator (PI) Scheme
Contact
Search the site
Fleur Hudson, Head of Trial and Study Management
UCL Profile of Fleur Hudson
Research Areas
Cancer
HIV
Tuberculosis
Neurodegenerative diseases
Methodology
Related Studies
ARREST
FORTE
ICOS
INITIO
RIVER
START
STRIVE
TICO
Related News
'25 at 25': Saving lives with early HIV treatment
22 Jan 2024
Home
About Us
Our People
Fleur Hudson
